Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2002;106:1460-1464
Published online before print August 26, 2002, doi: 10.1161/01.CIR.0000030184.70207.FF
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
106/12/1460    most recent
01.CIR.0000030184.70207.FFv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pleiner, J.
Right arrow Articles by Wolzt, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pleiner, J.
Right arrow Articles by Wolzt, M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Antioxidants
Hazardous Substances DB
*ASCORBIC ACID
*NITROGLYCERIN
*SODIUM ASCORBATE
Related Collections
Right arrow Other diabetes

(Circulation. 2002;106:1460.)
© 2002 American Heart Association, Inc.


Clinical Investigation and Reports

High Doses of Vitamin C Reverse Escherichia coli Endotoxin–Induced Hyporeactivity to Acetylcholine in the Human Forearm

Johannes Pleiner, MD; Friedrich Mittermayer, MD; Georg Schaller, MD; Raymond J. MacAllister, MD, FRCP; Michael Wolzt, MD

From the Department of Clinical Pharmacology, University of Vienna, Austria, and Centre for Clinical Pharmacology and Therapeutics (R.J.M.), Department of Medicine, University College London, UK.

Correspondence to Michael Wolzt, MD, Department of Clinical Pharmacology, Allgemeines Krankenhaus Wien, Währinger Gürtel 18-20, A-1090 Vienna, Austria. E-mail michael.wolzt{at}univie.ac.at

Background— Acute inflammation causes endothelial vasodilator dysfunction that may be mediated by oxidative stress.

Methods and Results— In this randomized, double-blind, crossover study, forearm blood flow responses to acetylcholine (ACh) (endothelium-dependent dilator) and glyceryl-trinitrate (GTN) (endothelium-independent dilator) were assessed before and after induction of acute systemic inflammation by low doses of Escherichia coli endotoxin (LPS) (20 IU/kg IV) in 8 healthy volunteers. The acute effect of intra-arterial vitamin C (24 mg/min) or placebo was studied 4 hours after LPS, respectively. Vitamin C alone was administered in control experiments. LPS administration caused systemic vasodilation, increased white blood count, elevated body temperature, and reduced vitamin C plasma concentrations. LPS decreased the responses of forearm blood flow to ACh by 30% (P<0.05) but not to GTN. Vitamin C completely restored the response to ACh, which was comparable with that observed under baseline conditions. Vitamin C had no effect on basal blood flow or ACh- or GTN-induced vasodilation in control subjects.

Conclusions— Our data demonstrate that impaired endothelial vasodilation caused by E coli endotoxemia can be counteracted by high doses of antioxidants in vivo. Oxidative stress may play an important role in the pathogenesis of endothelial dysfunction during inflammation.


Key Words: inflammation • endothelial function • oxidative stress • vitamin C




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
F. Mittermayer, J. Pleiner, G. Schaller, S. Zorn, K. Namiranian, S. Kapiotis, G. Bartel, M. Wolfrum, M. Brugel, J. Thiery, et al.
Tetrahydrobiopterin corrects Escherichia coli endotoxin-induced endothelial dysfunction
Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1752 - H1757.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Pleiner, G. Schaller, F. Mittermayer, S. Zorn, C. Marsik, S. Polterauer, S. Kapiotis, and M. Wolzt
Simvastatin Prevents Vascular Hyporeactivity During Inflammation
Circulation, November 23, 2004; 110(21): 3349 - 3354.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
S. P. Didion, D. A. Kinzenbaw, P. E. Fegan, L. A. Didion, and F. M. Faraci
Overexpression of CuZn-SOD Prevents Lipopolysaccharide-Induced Endothelial Dysfunction
Stroke, August 1, 2004; 35(8): 1963 - 1967.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. Hernanz, A. M. Briones, M. J. Alonso, E. Vila, and M. Salaices
Hypertension alters role of iNOS, COX-2, and oxidative stress in bradykinin relaxation impairment after LPS in rat cerebral arteries
Am J Physiol Heart Circ Physiol, July 1, 2004; 287(1): H225 - H234.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. Pleiner, F. Mittermayer, G. Schaller, C. Marsik, R. J. MacAllister, and M. Wolzt
Inflammation-induced vasoconstrictorhyporeactivity is caused by oxidative stress
J. Am. Coll. Cardiol., November 5, 2003; 42(9): 1656 - 1662.
[Abstract] [Full Text] [PDF]